{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:19:16Z","timestamp":1768583956307,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jconrel.2016.07.055","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T23:57:11Z","timestamp":1470268631000},"page":"141-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Repeated fractional intradermal dosing of an inactivated polio vaccine by a single hollow microneedle leads to superior immune responses"],"prefix":"10.1016","volume":"242","author":[{"given":"Pim","family":"Schipper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"van der Maaden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Romeijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cees","family":"Oomens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Jiskoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joke","family":"Bouwstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.07.055_bb0005","series-title":"Polio Eradication and Endgame Strategic Plan 2013\u20132018","author":"World Health Organization","year":"2013"},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2016.07.055_bb0010","doi-asserted-by":"crossref","first-page":"S459","DOI":"10.1093\/infdis\/jiu128","article-title":"Affordable inactivated poliovirus vaccine: strategies and progress","volume":"210","author":"Okayasu","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2016.07.055_bb0015","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","article-title":"Vaccine-derived polioviruses","volume":"210","author":"Burns","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2016.07.055_bb0020","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/infdis\/jiu184","article-title":"Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden","volume":"210","author":"Platt","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0025","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.1016\/j.vaccine.2012.09.059","article-title":"Adjuvants and inactivated polio vaccine: a systematic review","volume":"30","author":"Hawken","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0030","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.vaccine.2015.03.011","article-title":"Alternative delivery of a thermostable inactivated polio vaccine","volume":"33","author":"Kraan","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0035","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.vaccine.2015.02.069","article-title":"The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model","volume":"33","author":"Norton","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0040","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.4161\/hv.32253","article-title":"Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system","volume":"10","author":"White","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105374","article-title":"Alternative inactivated poliovirus vaccines adjuvanted with Quillaja brasiliensis or Quil-a saponins are equally effective in inducing specific immune responses","volume":"9","author":"de Costa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100879","article-title":"Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01","volume":"9","author":"Dietrich","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0055","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.vaccine.2013.11.101","article-title":"A mucosal adjuvant for the inactivated poliovirus vaccine","volume":"32","author":"Steil","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0060","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.vaccine.2012.12.076","article-title":"Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains","volume":"31","author":"Westdijk","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0065","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1007\/s11095-016-1965-6","article-title":"Determination of Depth-Dependent Intradermal Immunogenicity of Adjuvanted Inactivated Polio Vaccine Delivered by Microinjections via Hollow Microneedles","volume":"33","author":"Schipper","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.biologicals.2014.05.007","article-title":"Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies","volume":"42","author":"Kumru","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4161\/hv.34299","article-title":"Tailored immunity by skin antigen-presenting cells","volume":"11","author":"Levin","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0080","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1016\/j.ijid.2011.10.002","article-title":"Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines","volume":"16","author":"Cadorna-Carlos","year":"2012","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0085","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jconrel.2012.01.042","article-title":"Microneedle technologies for (trans)dermal drug and vaccine delivery","volume":"161","author":"van der Maaden","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0090","first-page":"1846","article-title":"Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats","volume":"31","author":"van der Maaden","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0095","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1021\/acs.langmuir.5b01262","article-title":"Layer-by-layer assembly of inactivated poliovirus and N-trimethyl chitosan on pH-sensitive microneedles for dermal vaccination","volume":"31","author":"van der Maaden","year":"2015","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0100","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/infdis\/jiu624","article-title":"Intradermal inactivated poliovirus vaccine: a preclinical dose-finding study","volume":"211","author":"Kouiavskaia","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.01.089","article-title":"Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque","author":"Edens","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0110","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/infdis\/jiu841","article-title":"Comparison of the immunogenicity of various booster doses of inactivated polio vaccine delivered intradermally versus intramuscularly to HIV-infected adults","volume":"211","author":"Troy","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0115","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1016\/j.vaccine.2015.09.039","article-title":"Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: a randomized controlled trial","volume":"33","author":"Anand","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0120","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1073\/pnas.0706296105","article-title":"Antigen kinetics determines immune reactivity","volume":"105","author":"Johansen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2016.07.055_bb0125","doi-asserted-by":"crossref","first-page":"S540","DOI":"10.1093\/clinids\/6.Supplement_2.S540","article-title":"Standardization of poliovirus neutralizing antibody tests","volume":"6","author":"Albrecht","year":"1984","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0130","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1034\/j.1398-9995.2000.00501.x","article-title":"Aluminium-induced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations","volume":"55","author":"Vogelbruch","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0135","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1016\/j.vaccine.2009.08.047","article-title":"CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus","volume":"27","author":"Yang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0140","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1056\/NEJMoa0909383","article-title":"Fractional doses of inactivated poliovirus vaccine in Oman","volume":"362","author":"Mohammed","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0145","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1086\/651611","article-title":"Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba","volume":"201","author":"Resik","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0150","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0155","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1016\/j.vaccine.2013.05.104","article-title":"Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults","volume":"31","author":"Soonawala","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0160","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1473-3099(11)70190-6","article-title":"Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6\u20139months in Moradabad, India: a community-based, randomised controlled trial","volume":"12","author":"Estivariz","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0165","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.vaccine.2014.11.025","article-title":"Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba","volume":"33","author":"Resik","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri2217","article-title":"Germinal centres: role in B-cell physiology and malignancy","volume":"8","author":"Klein","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4049\/jimmunol.178.1.67","article-title":"Regulation of memory antibody levels: the role of persisting antigen versus plasma cell life span","volume":"178","author":"Gatto","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0180","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4049\/jimmunol.180.2.1131","article-title":"CD8 T cell expansion and memory differentiation are facilitated by simultaneous and sustained exposure to antigenic and inflammatory milieu","volume":"180","author":"Shaulov","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0185","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/eji.200535730","article-title":"Long-lived memory CD8+ T cells are programmed by prolonged antigen exposure and low levels of cellular activation","volume":"36","author":"Bachmann","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1074-7613(00)80461-6","article-title":"The duration of antigenic stimulation determines the fate of naive and effector T cells","volume":"8","author":"Iezzi","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1074-7613(00)80308-8","article-title":"Duration of TCR stimulation determines costimulatory requirement of T cells","volume":"5","author":"Kundig","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2016.07.055_bb0200","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/jid.2011.346","article-title":"Intradermal immunization triggers epidermal Langerhans cell mobilization required for CD8 T-cell immune responses","volume":"132","author":"Liard","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2016.07.055_bb0205","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ni852","article-title":"Langerhans cells renew in the skin throughout life under steady-state conditions","volume":"3","author":"Merad","year":"2002","journal-title":"Nat. Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916305016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916305016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:16:13Z","timestamp":1749039373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916305016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":41,"alternative-id":["S0168365916305016"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.07.055","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeated fractional intradermal dosing of an inactivated polio vaccine by a single hollow microneedle leads to superior immune responses","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.07.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}